Joe Biden's Price Controls on Prescription Drugs

WSJ Opinion: Potomac Watch - Podcast autorstwa Paul Gigot, The Wall Street Journal

The president announces the first 10 drugs for which the government will "negotiate" prices under the Inflation Reduction Act. What will this do to the incentive to develop new cures and launch generic alternatives? Plus, the plan faces legal challenges over whether the threatened penalty of a 1,900% tax is constitutional. Learn more about your ad choices. Visit megaphone.fm/adchoices

Visit the podcast's native language site